Pergolide Treatment for Substance Abusers - 4

This study has been completed.
Sponsor:
Collaborator:
New York State Psychiatric Institute
Information provided by:
National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:
NCT00000269
First received: September 20, 1999
Last updated: August 16, 2005
Last verified: October 1995
  Purpose

The purpose of this study is to evaluate the safety and efficacy of pergolide for cocaine dependence.


Condition Intervention Phase
Cocaine-Related Disorders
Substance-Related Disorders
Drug: Pergolide
Phase 2

Study Type: Interventional
Study Design: Primary Purpose: Treatment
Official Title: Pergolide Treatment for Substance Abusers

Resource links provided by NLM:


Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:
  • Side effects
  • Craving
  • Drug use
  • Improvement in functioning
  • Tolerability

Estimated Enrollment: 0
Study Start Date: October 1995
Estimated Study Completion Date: December 2001
  Eligibility

Ages Eligible for Study:   18 Years to 55 Years
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria

Please contact site for information.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00000269

Locations
United States, New York
New York State Psychiatric Institute
New York, New York, United States, 10032
Sponsors and Collaborators
New York State Psychiatric Institute
Investigators
Principal Investigator: Herbert Kleber, M.D. New York State Psychiatric Institute
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00000269     History of Changes
Other Study ID Numbers: NIDA-09236-4, P50-09236-4
Study First Received: September 20, 1999
Last Updated: August 16, 2005
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Cocaine-Related Disorders
Substance-Related Disorders
Mental Disorders
Pergolide
Dopamine Agonists
Dopamine Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs

ClinicalTrials.gov processed this record on April 17, 2014